UK residents have cut their grocery spending by approximately £780 million ($1 billion) over the past year due to the rising popularity of weight-loss drugs.
According to a study by 'Worldpanel by Numerator', a company specializing in consumer data analysis, households where at least one member took GLP-1 agonist-based weight-loss drugs bought 299 million fewer food items compared to normal years. Users also reported reduced hunger and lower consumption of products like chocolate and chips.
Companies and brands are adapting to shifting demand. For instance, 'J Sainsbury' launched a line of high-protein ready meals in smaller portions, while 'Marks & Spencer Group' offers nutritionally enhanced products. Restaurants and bars are also adjusting their menus to account for the popularity of weight-loss drugs.
The study involved over 11,500 households in the UK.
